- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07634796
Development of a Pain Rehabilitation Program for Chronic Pain After SCI
Feasibility of a New Digital Pain Rehabilitation Program for People With SCI
Pain rehabilitation programs are essential for optimal treatment of chronic pain and are usually based on the biopsychosocial model. This is, however, not standard care for people with chronic pain after a spinal cord injury (SCI) due to a biomedical focused perspective of SCI and lack of adapted programs.
The aims of this feasibility study:
- Develop a new digital pain rehabilitation program, adapted for the needs of people living with an SCI.
- To investigate the feasibility and acceptability of a new digital pain rehabilitation program.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
This study follows the guidelines of Medical Research Council for complex interventions and the proposed iterative feasibility process to improve and prepare the intervention for future testing in an RCT study. The research group will, toghether with a reference groups, develop a digital intervention porposal. The program will be a team-based, goal-oriented program for patients with spinal cord injury (SCI) and chronic pain.
In this study, eligible participants are included in an 8 week pain rehabilitation program. The program is developed through user-involvement i.e. together with clinicians (experienced in pain rehabilitation and/or SCI rehabilitation), stakeholders, researchers and individuals with SCI. The program will include video material for education, home exercises and group discussions led by clinicians with long experience in pain rehabilitation and SCI.
The participants will fill in self-assessed questionaries at baseline and after the finish of the program about their pain, sleep, mood and quality of life. After the program some of the participants will be asked to participate in semi-structured interviews about how they navigate and engage with different components of the program. The patients will be recruited during a rutine follow up at an SCI clinic.
Seven factors will be studied to assess the feasibility and acceptability of the program, based on set goals according to the Traffic Light method.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Gunilla Stenberg, Docent
- Telefonnummer: +46 90 7869895
- E-post: gunilla.stenberg@umu.se
Studer Kontakt Backup
- Navn: Sofia Björkbacka, MSc
- Telefonnummer: 0046907869349
- E-post: sofia.bjorkbacka@umu.se
Studiesteder
-
-
-
Umeå, Sverige, 90736
- Inst. Community Medicine and Rehabilitation
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- two years since injury
- Stable pain medication?
Exclusion Criteria:
- severe cognitive impairment
- Alcohol or drug abuse
- does not understand Swedish
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Spinal cord injury (SCI) and chronic pain
People with chronic pain after spinal cord injury
|
8- week pain rehabilitation program.
The first meeting of the program is located at a hospital facility and thereafter they will meet at a digital platform.The program include education, home exercises and group meetings.
The program consists of 4 modules.
1. Physical exercise and ergonomics.
2. Structure and recovery.
3. Employment/occupation and social support.
4. ACT and coping.
Each module lasts for two weeks.
The program will include video material for education, home exercises and group discussions led by clinicians with long experience in pain rehabilitation and SCI.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Recruitment rate, number recruited per quarter
Tidsramme: At enrollment
|
Continue=6 Solve=4 Stop=3
|
At enrollment
|
|
Number of participant with treatment-related advere events as assessed by...
Tidsramme: From enrollment to the end of tretment at 8 weeks
|
From enrollment to the end of tretment at 8 weeks
|
|
|
Participant retention- Completion rates
Tidsramme: The end of the 8- week program
|
>75% continue, 50-75% Solve, <50% stop
|
The end of the 8- week program
|
|
Program Adherence
Tidsramme: The end of the 8-week program
|
Continue >75%, solve 50-75%, stop <50%
|
The end of the 8-week program
|
|
Patients' self-perceived relevance, timing and mode of delivery
Tidsramme: >70% Continue, Solve 50-70%, Stop <50%
|
Patient evaluation, satisfied patients
|
>70% Continue, Solve 50-70%, Stop <50%
|
|
Assessment procedure acceptance- Patient evaluations, proportions of completed questionnaires
Tidsramme: At the end of the 8-week program
|
>80% continue, 50-80% solve, <50% stop
|
At the end of the 8-week program
|
|
Fidelity of delivery - Process evaluations
Tidsramme: End of the 8-week program
|
End of the 8-week program
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Smerte
- Nevrologiske manifestasjoner
- Sykdommer i sentralnervesystemet
- Sykdommer i nervesystemet
- Sår og skader
- Nevromuskulære sykdommer
- Sykdommer i det perifere nervesystemet
- Nevroatferdsmanifestasjoner
- Traumer, nervesystemet
- Ryggmargssykdommer
- Perseptuelle forstyrrelser
- Patologiske tilstander, tegn og symptomer
- Tegn og symptomer
- Kronisk smerte
- Nevralgi
- Ryggmargsskader
- Agnosia
Andre studie-ID-numre
- 2023-04232-01
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .